ASP Isotopes (NASDAQ:ASPI) Stock Price Up 10% - Should You Buy?

Key Points

• ASP Isotopes Inc. (NASDAQ: ASPI) saw its stock price increase by 10%, closing at $10.63 after trading as high as $10.31.
• Analysts at Canaccord Genuity raised their price target on ASP Isotopes from $8.50 to $11.00 and rated the stock as a "buy."
• The company has a market capitalization of $886.78 million and a high beta of 3.35, suggesting more volatility compared to the market.
• Recent institutional trading includes BNP Paribas and SBI Securities purchasing new stakes, with 16.80% of shares now held by institutional investors.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report)'s share price rose 10% on Friday . The stock traded as high as $10.31 and last traded at $10.63. Approximately 1,471,131 shares traded hands during mid-day trading, a decline of 49% from the average daily volume of 2,862,987 shares. The stock had previously closed at $9.66.

Analyst Ratings Changes

Separately, Canaccord Genuity Group upped their price target on shares of ASP Isotopes from $8.50 to $11.00 and gave the stock a "buy" rating in a report on Wednesday, May 21st.

ASP Isotopes Trading Up 9.4%

The stock has a 50 day moving average of $8.03 and a 200 day moving average of $6.16. The firm has a market cap of $886.78 million, a P/E ratio of -17.51 and a beta of 3.35. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.21 and a quick ratio of 7.17.

Institutional Trading of ASP Isotopes

Several large investors have recently modified their holdings of ASPI. BNP Paribas Financial Markets bought a new stake in shares of ASP Isotopes in the fourth quarter worth about $34,000. SBI Securities Co. Ltd. grew its stake in shares of ASP Isotopes by 84.8% in the first quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company's stock worth $44,000 after purchasing an additional 4,299 shares during the last quarter. Avantax Advisory Services Inc. bought a new stake in shares of ASP Isotopes in the fourth quarter worth about $45,000. Russell Investments Group Ltd. grew its stake in shares of ASP Isotopes by 56.3% in the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock worth $46,000 after purchasing an additional 3,682 shares during the last quarter. Finally, Covestor Ltd bought a new stake in shares of ASP Isotopes in the fourth quarter worth about $54,000. 16.80% of the stock is owned by institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.